Tags

Type your tag names separated by a space and hit enter

Mycoplasma genitalium and Trichomonas vaginalis: addressing disparities and promoting public health control of two emerging sexually transmitted infections.
Curr Opin Pediatr. 2020 Aug; 32(4):482-488.CO

Abstract

PURPOSE OF REVIEW

Mycoplasma genitalium (M. genitalium) and Trichomonas vaginalis (T. vaginalis), sexually transmitted infections that remain non-reportable in the United States, may lead to pelvic inflammatory disease (PID) and adverse pregnancy outcomes if left untreated. Prevalence estimates have highlighted socioeconomic and racial/ethnic disparities in rates of infection. This review summarizes the recent literature on M. genitalium and T. vaginalis with a focus on the epidemiology, screening, and treatment of M. genitalium and T. vaginalis.

RECENT FINDINGS

The burden of T. vaginalis testing remains on women. Antimicrobial resistance is of great concern for M. genitalium. Comprehensive screening and treatment guidelines present an opportunity to address these public health concerns.

SUMMARY

M. genitalium and T. vaginalis infections disproportionately affect sexual and racial/ethnic minorities and those facing socioeconomic disparities. The availability of nucleic acid amplification test testing has facilitated accurate diagnosis of both disorders. Safe and efficacious treatments are available for treatment of both disorders. Integrating macrolide resistance testing into treatment algorithms for M. genitalium and dual antibiotic therapy may prove a useful strategy for future US-based guidance. Public health reporting and increased public awareness campaigns are key next steps to addressing the observed reproductive health disparities.

Authors+Show Affiliations

aAdolescent Medicine, John Hopkins University School of Medicine bJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32520821

Citation

Korich, Faye, et al. "Mycoplasma Genitalium and Trichomonas Vaginalis: Addressing Disparities and Promoting Public Health Control of Two Emerging Sexually Transmitted Infections." Current Opinion in Pediatrics, vol. 32, no. 4, 2020, pp. 482-488.
Korich F, Reddy NG, Trent M. Mycoplasma genitalium and Trichomonas vaginalis: addressing disparities and promoting public health control of two emerging sexually transmitted infections. Curr Opin Pediatr. 2020;32(4):482-488.
Korich, F., Reddy, N. G., & Trent, M. (2020). Mycoplasma genitalium and Trichomonas vaginalis: addressing disparities and promoting public health control of two emerging sexually transmitted infections. Current Opinion in Pediatrics, 32(4), 482-488. https://doi.org/10.1097/MOP.0000000000000909
Korich F, Reddy NG, Trent M. Mycoplasma Genitalium and Trichomonas Vaginalis: Addressing Disparities and Promoting Public Health Control of Two Emerging Sexually Transmitted Infections. Curr Opin Pediatr. 2020;32(4):482-488. PubMed PMID: 32520821.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mycoplasma genitalium and Trichomonas vaginalis: addressing disparities and promoting public health control of two emerging sexually transmitted infections. AU - Korich,Faye, AU - Reddy,Neha G, AU - Trent,Maria, PY - 2020/6/11/pubmed PY - 2020/6/11/medline PY - 2020/6/11/entrez SP - 482 EP - 488 JF - Current opinion in pediatrics JO - Curr. Opin. Pediatr. VL - 32 IS - 4 N2 - PURPOSE OF REVIEW: Mycoplasma genitalium (M. genitalium) and Trichomonas vaginalis (T. vaginalis), sexually transmitted infections that remain non-reportable in the United States, may lead to pelvic inflammatory disease (PID) and adverse pregnancy outcomes if left untreated. Prevalence estimates have highlighted socioeconomic and racial/ethnic disparities in rates of infection. This review summarizes the recent literature on M. genitalium and T. vaginalis with a focus on the epidemiology, screening, and treatment of M. genitalium and T. vaginalis. RECENT FINDINGS: The burden of T. vaginalis testing remains on women. Antimicrobial resistance is of great concern for M. genitalium. Comprehensive screening and treatment guidelines present an opportunity to address these public health concerns. SUMMARY: M. genitalium and T. vaginalis infections disproportionately affect sexual and racial/ethnic minorities and those facing socioeconomic disparities. The availability of nucleic acid amplification test testing has facilitated accurate diagnosis of both disorders. Safe and efficacious treatments are available for treatment of both disorders. Integrating macrolide resistance testing into treatment algorithms for M. genitalium and dual antibiotic therapy may prove a useful strategy for future US-based guidance. Public health reporting and increased public awareness campaigns are key next steps to addressing the observed reproductive health disparities. SN - 1531-698X UR - https://www.unboundmedicine.com/medline/citation/32520821/Mycoplasma_genitalium_and_Trichomonas_vaginalis:_addressing_disparities_and_promoting_public_health_control_of_two_emerging_sexually_transmitted_infections L2 - https://doi.org/10.1097/MOP.0000000000000909 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.